Plasma Resilience: Europe's Lifeline
Human plasma, a protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Despite its importance, Europe's plasma supply chain is vulnerable, relying on the generosity of human donors. Over 12 million people in Europe donation plasma annually, following rigorous safety standards set by EU Member States and international organizations like the International Quality Plasma Program (IQPP) and the Plasma Protein Therapeutics Association (PPTA).
However, this is not sufficient, as nearly 40% of plasma used for European medicines is imported from the United States.
Therapies made from plasma exist only thanks to the generosity of real people.
Author's summary: Europe relies heavily on human plasma donations.
More News
- The first week of testimony in Brian Walshe’s murder trial is over. Here are takeaways from Day 5
- Netanyahu: Won’t quit politics for pardon in corruption trial
- Golden State Warriors vs Cleveland Cavaliers | Live Play-By-Play & Reactions
- CHEFS (@chefs_podcast) - Instagram photos and videos
- Is London The Top City In The World For This Cuisine? These Chefs Say Yes
- Over 4,000 gallons of oil and toxic wastewater spill in San Ardo
- Solidarity on Trial in Greece
- Golden State Warriors vs Cleveland Cavaliers regular season game: Full injury report, who's out, and more
- Spillcontrol – Spill Control
- Spill and pollution response